Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Journal of the American College of Cardiology|June 25, 2025
Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic ShockJacob Eifer Møller, Rasmus Paulin Beske, Lisette Okkels Jensen, et al.
JAMA Cardiology|October 27, 2024
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock: A Substudy of the DanGer Shock Randomized Clinical TrialNanna Louise Junker Udesen, Rasmus Paulin Beske, Christian Hassager, et al.
Journal of the American College of Cardiology|November 12, 2025
Sex-Specific Microaxial Flow Pump Use and Outcomes in Infarct-Related Cardiogenic Shock in the DanGer Shock TrialNorman Mangner, Rasmus Paulin Beske, Christian Hassager, et al.
Blood|July 29, 2025
Casein kinase 1α essentially regulates thrombopoiesis by driving megakaryocyte maturation and cytoskeleton organizationFerdinand Kollotzek, Kristina Mott, Melina Fischer, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Bleeding in Patients With Infarct-Related Cardiogenic Shock: A DanGer Shock SubstudyRikke Sørensen, Jacob Eifer Møller, Christophe Vandenbriele, et al.
Cardiovascular Diabetology|March 13, 2026
Cohort profile: The DIabetes and ST-segment Elevation Myocardial Infarction (DISTEMI) StudyClara Möser, Katsiaryna Prystupa, Martin Schön, et al.
European Heart Journal. Acute Cardiovascular Care|January 29, 2026
Escalation of Mechanical Circulatory Support in Patients with STEMI-related Cardiogenic Shock: A post-hoc Analysis of the DanGer Shock TrialBenedikt Schrage, Rasmus Paulin Beske, Christian Hassager, et al.
Circulation|June 5, 2024
Aortic Valve Stenosis Causes Accumulation of Extracellular Hemoglobin and Systemic Endothelial DysfunctionChristine Quast, Florian Bönner, Amin Polzin, et al.
JACC. Cardiovascular Interventions|September 24, 2025
Percutaneous Coronary Intervention in Multivessel Disease and Infarct-Related Cardiogenic Shock: A DanGer Shock SubstudyJasmine M Marquard, Rasmus P Beske, Christian Hassager, et al.
Circulation Research|December 21, 2019
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1Tobias Petzold, Manuela Thienel, Lisa Dannenberg, et al.
Pageof 19